News center More...

27 2025-05
Gluetacs was honored with the “Future Star Alumni Enterprise Award” at the 6th University of Chinese Academy of Sciences (UCAS) Alumni Innovation Forum.
15 2025-03
Gluetacs Therapeutics and Fudan University’s Sun Tao/Jiang Chen team develop a PROTAC-loaded nanocapsule targeting BRD4 degradation to break through the radiochemotherapy resistance bottleneck in glioblastoma
15 2025-03
Gluetacs Therapeutics and Fudan University’s Sun Tao/Jiang Chen team develop a PROTAC-loaded nanocapsule targeting BRD4 degradation to break through the radiochemotherapy resistance bottleneck in glioblastoma
04 2025-01
Conference Express |Gluetacs Therapeutics Will Attend the 2025 J.P. Morgan & BIOTECH SHOWCASE Annual International Conference
28 2024-12
Good news! Gluetacs Therapeutics won Top 100 of the Shanghai High-Value Patent Operation Competition and awarded the title of Director Unit of the National Biopharmaceutical Enterprise Platform
24 2024-12
Gluetacs was honored with 2024 Shanghai high-tech enterprises and 2024 Special Fund for Promoting the Integration of Industry and Education in the Lingang Special Area of the China (Shanghai) Pilot Free Trade Zone
23 2024-12
Gluetacs Therapeutics Co-reported PARP1 Degrader Demonstrating Superior Safety and Efficacy in BRCA-Deficient Tumors Published in Cell Death & Disease